ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MTNB Matinas Biopharma Holdings Inc

0.2363
0.0063 (2.74%)
Dec 06 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,190,655
Bid Price
Ask Price
News -
Day High 0.24

Low
0.1103

52 Week Range

High
0.89

Day Low 0.2167
Company Name Stock Ticker Symbol Market Type
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0063 2.74% 0.2363 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.24 0.2167 0.24 0.24 0.23
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,109 1,190,655 $ 0.2261972 $ 269,323 - 0.1103 - 0.89
Last Trade Time Type Quantity Stock Price Currency
20:00:00 53,231 $ 0.24 USD

Matinas Biopharma Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
52.14M 217.26M - 3.19M -21M -0.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Matinas Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MTNB Message Board. Create One! See More Posts on MTNB Message Board See More Message Board Posts

Historical MTNB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.210.240.20010.2137091991,8780.026312.52%
1 Month0.29960.30560.20010.22761831,545,381-0.0633-21.13%
3 Months0.15910.890.11720.49246449,813,6280.077248.52%
6 Months0.38740.890.11030.47619414,945,400-0.1511-39.0%
1 Year0.620.890.11030.48007532,707,012-0.3837-61.89%
3 Years1.202.220.11030.84936912,005,017-0.9637-80.31%
5 Years0.79842.490.11030.91906851,862,949-0.5621-70.4%

Matinas Biopharma Description

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Your Recent History

Delayed Upgrade Clock